Related Experiment Video
Updated: Jan 28, 2026

Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b
Published on: November 11, 2016
[Identifying Inhibitors of USP7-HDM2 Protein-Protein Interaction (PPI) by the in Silico Fragment-mapping Method]
Kensuke Misawa1, Shin-Ichiro Ozawa1, Tomoki Yoshida1
1Department of Pharmaceutical Sciences, School of Pharmacy, Kitasato University.
Abstract:
Proteolysis mediated by the ubiquitin-proteome system plays an important role in cancer. Recently, a deubiquitinating enzyme, ubiquitin-specific protease 7 (USP7) has attracted attention as a key regulator of the p53-human double minute 2 (HDM2) pathway in cancer cells. Although some USP7 enzyme inhibitors have been identified, issues related to activity and selectivity prevent their therapeutic application. In this study, we aimed to search for novel USP7-HDM2 protein-protein interaction (PPI) inhibitors that do not affect the USP7 enzyme activity. Using the fragment-mapping program Fsubsite and the canonical subsite-fragment database (CSFDB) developed in our laboratory, we mapped a variety of fragments onto USP7 protein and constructed 3D-pharmacophore models based on the arrangement patterns of the mapped fragments. Finally, we performed 3D pharmacophore-based virtual screening of a commercial compound database and successfully selected promising USP7-HDM2 PPI inhibitor candidates.
Insights
Researchers identified new ways to inhibit cancer cell pathways by targeting USP7-HDM2 protein interactions. These novel inhibitors offer potential therapeutic strategies without affecting USP7 enzyme activity.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- The ubiquitin-proteome system regulates proteolysis, crucial in cancer development.
- Ubiquitin-specific protease 7 (USP7) is a key regulator of the p53-human double minute 2 (HDM2) pathway in cancer cells.
- Existing USP7 enzyme inhibitors face challenges with activity and selectivity for therapeutic use.
Purpose of the Study:
- To discover novel inhibitors targeting the USP7-HDM2 protein-protein interaction (PPI).
- To develop inhibitors that specifically block USP7-HDM2 PPI without impacting USP7 enzyme activity.
Main Methods:
- Utilized the Fsubsite program and canonical subsite-fragment database (CSFDB) for fragment mapping on USP7.
- Constructed 3D-pharmacophore models based on fragment arrangement patterns.
- Performed 3D pharmacophore-based virtual screening of a commercial compound database.
Main Results:
- Successfully mapped fragments onto the USP7 protein.
- Developed 3D-pharmacophore models for USP7.
- Identified promising USP7-HDM2 PPI inhibitor candidates through virtual screening.
Conclusions:
- Novel USP7-HDM2 PPI inhibitors were identified.
- The developed pharmacophore models and screening approach are effective for discovering PPI inhibitors.
- These candidates hold potential for cancer therapy by targeting the USP7-HDM2 pathway.
Related Concept Videos
Microtubule Associated Proteins (MAPs)
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Protein-protein Interfaces
Protein and Protein Structure
A protein's shape is critical to its function. For example, an enzyme...
What are Proteins?
G-protein Coupled Receptors

